Paper 69 - PRELIMINARY DOSE-VOLUME CONSTRAINTS PREDICTING SUBCUTANEOUS TISSUE FIBROSIS FOR LIMB SARCOMA USING THE VORTEX AND IMRIS TRIALS.

Author(s)

• 

  Rita Simoes, PhD (she/her/hers)

  Senior Radiographer Researcher
  The Royal Marsden hospital
  London, England, United Kingdom

  Slides

Co-Author(s)

• 

  Beatrice Seddon, PhD (she/her/hers)

  Consultant Clinical Oncologist
  University College London Hospitals
  London, England, United Kingdom
• 

  Martin H. Robinson, PhD (he/him/his)

  Honorary Reader in Oncology
  Sheffield University
  Hathersage, England, United Kingdom
• SS

  Shumona Shelly, BSc

  Cancer Research UK & UCL Cancer Trials Centre
  London, England, United Kingdom
• TA

  Temi Adedoyin, BSc

  Cancer Research UK & UCL Cancer Trials Centre
  London, England, United Kingdom
• HD

  Hakim-Moulay Dehbi, PhD

  University College London
  London, England, United Kingdom
• PG

  Piers Gaunt, PhD (he/him/his)

  Principal biostatistician
  Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham
  Birmingham, England, United Kingdom
• AH

  Ana Hughes, BSc

  8- Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham
  Birmingham, England, United Kingdom
• EM

  Elizabeth Miles, MPhil

  Radiotherapy Trials Quality Assurance (RTTQA) group
  Northwood, England, United Kingdom
• PH

  Peter Hoskin, PhD

  Professor in Clinical Oncology
  University of Manchester
  Manchester, England, United Kingdom
• kH

  kevin Harrington, PhD

  The Institute of Cancer research
  London, England, United Kingdom
• sG

  sarah Gulliford, PhD

  University College London Hospitals
  London, England, United Kingdom
• 

  Aisha B. Miah, PhD

  Clinical Oncology Consultant
  The Royal Marsden Hospital
  London, England, United Kingdom